<DOC>
<DOCID> CNA_ENG_20070322.0035.LDC2009T13 </DOCID>
<DOCTYPE SOURCE="newswire"> NEWS STORY </DOCTYPE>
<DATETIME> 2007-03-22 </DATETIME>
<BODY>
<HEADLINE>
TAIWANESE, DUTCH COMPANIES FORGE TIES TO PRODUCE FLU VACCINES
</HEADLINE>
<TEXT>
<P>
Taipei,  March  22 (CNA) 03/22/07  21:30:57 (By Elizabeth Hsu)
</P>
<P>
A Taichung County-based biotechnology company sealed a strategic
alliance Thursday with Crucell -- a Dutch company of worldwide
renown for the production and marketing of vaccines  and
antibodies  against infectious  diseases  --  to mass-produce
influenza vaccines.
</P>
<P>
Adimmune Corp. Chairman Liao Chih-cheng signed a technology
transfer agreement with Crucell chief executive officer Ronald
Brus in a ceremony also attended by former Premier Frank Hsieh,
Vice Minister of Economic Affairs Shih Yen-shiang, and Menno
Goedhart, chief of the Netherlands Trade and Investment Office in
Taiwan
</P>
<P>
Shih gave Adimmune Corp. high praise, comparing the only human
vaccine manufacturer in Taiwan to the Taiwan Semiconductor
Manufacturing Company -- the world's leading semiconductor
producer.
</P>
<P>
Liao said his company is expected to produce 20 million doses of
flu vaccines a year by 2010.
</P>
<P>
According to Crucell, the sale of flu vaccines accounts for 14
percent of the world's total vaccination market, with total
global flu vaccine sales reaching nearly US$2 billion in 2005.
</P>
</TEXT>
</BODY>
</DOC>
